Immunoprotein Diagnostic Testing Market - Global Opportunity Analysis and Industry Forecast, 2016-2023

Friday, May 19, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, May 18, 2017 /PRNewswire/ -- Immunoprotein Diagnostic Testing Market by Technology (Radioimmunoassay, Immunoturbidity Assay, Chemiluminescence Assay, Immunoprotein Electrophoresis, Enzyme-Based Immunoassay, and Immunofluorescence Assay), by Type (C - reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Prealbumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, and Free Light Chain Diagnostic Test), and by Application (Autoimmune Disease Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing, and Toxicology Testing) - Global Opportunity Analysis and Industry Forecast, 2016-2023

Download the full report: is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body
system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiovascular, oncology, infectious diseases, and others, as they display an abnormal increase in their concentration when in a diseased state. Increase in incidence & prevalence of chronic diseases, rise in geriatric population, and growth in demand for early diagnostic services drive the market growth. However, complex regulatory framework for immunoprotein diagnostic testing limits the growth. The global immunoprotein diagnostic testing market is accounted for $16,485 million in 2016, and is estimated to reach $27,290 million by 2022, growing at a CAGR of 7.4% during the analysis period (2017-2023). The market is segmented on the basis of type, application, technology, and geography. By type, the market is categorized into C-reactive protein diagnostic test, complement system protein diagnostic test, prealbumin diagnostic test, haptoglobin diagnostic test, immunoglobulin diagnostic test, free light chain diagnostic test, and others. Applications covered in the study include autoimmune disease testing, infectious disease testing, allergy testing, endocrine testing, oncology testing, toxicology testing, and others. Based on technology, it is classified into radioimmunoassay, immunoturbidity assay, chemiluminescence assay, immunoprotein electrophoresis, enzyme-based immunoassay, immunofluorescence assay, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. KEY MARKET BENEFITS: The study provides an in-depth analysis of the global immunoprotein diagnostic testing market with current trends and future estimations to elucidate the investment pockets. Comprehensive analysis of factors that drive and restrict the growth of the market is provided. The report provides a quantitative analysis for the period of 2016-2023, which enables stakeholders to capitalize on prevailing market opportunities. Extensive analysis of different segments facilitates to understand the various products of the market. Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market. KEY MARKET SEGMENT: By Technology Radioimmunoassay Immunoturbidity Assay Chemiluminescence Assay Immunoprotein Electrophoresis Enzyme-Based Immunoassay Immunofluorescence Assay Others By Type C-reactive Protein Diagnostic Test Complement System Protein Diagnostic Test Prealbumin Diagnostic Test Haptoglobin Diagnostic Test Immunoglobulin Diagnostic Test Free Light Chain Diagnostic Test Others By Application Autoimmune Testing Infectious Disease Testing Allergy Testing Endocrine Testing Oncology Testing Toxicology Testing Others By Geography North America U.S. Canada Mexico Europe Germany UK France Spain Italy Others Asia Pacific Japan China India Others LAMEA Latin America Middle East Download the full report: ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Email: Tel: +44 208 816 85 48 Website:

To view the original version on PR Newswire, visit:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store